Table Of Contents
1 Introduction 13
1.1 Objectives Of The Study 13
1.2 Market Definition 13
1.3 Overview Of North America Transradial Access Market 13
1.4 Currency And Pricing 14
1.5 Limitation 14
1.6 Markets Covered 15
2 Market Segmentation 17
2.1 Markets Covered 17
2.2 Geographic Scope 18
2.3 Years Considered For The Study 19
2.4 Currency And Pricing 19
2.5 Research Methodology 20
2.6 Primary Interviews With Key Opinion Leaders 23
2.7 Secondary Sources 24
2.8 Assumptions 24
3 Market Overview 25
3.1 Drivers 27
3.1.1 Increasing Cases Of Obese Patients 27
3.1.2 Rising Number Of Heart Problems 28
3.1.3 Growing Use Of Radial Access In Oncology Field 29
3.1.4 Technological Adavancements 30
3.2 Restraints 31
3.2.1 Product Recalls And Failures 31
3.3 Opportunities 32
3.3.1 Emerging Markets 32
3.4 Challenges 33
3.4.1 Side Effects Of Transradial Access 33
3.4.2 Lack Of Skilled Professsionals 33
4 Executive Summary 34
5 Premium Insights 36
6 North America Transradial Access Market, By Product 45
6.1 Overview 46
6.2 Sheaths And Sheath Introducers 48
6.3 Mircrocatheters 49
6.4 Guidewires 50
6.5 Guiding Catheters 51
6.6 Intermediate Catheters 52
6.7 Accessories 53
7 North America Transradial Access Market, By Application 54
7.1 Overview 55
7.2 Cardiology 57
7.3 Peripheral Vascular 58
7.4 Neurovascular 59
8 North America Transradial Access Market, By Usage 60
8.1 Overview 61
8.2 Drug Administration 63
8.3 Fluid And Nutrition Administration 65
8.4 Diagnostics And Testing 67
8.5 Blood Transfusion 69
9 North America Transradial Access Market, By End User 71
9.1 Overview 72
9.2 Hospital 74
9.3 Clinics 75
9.4 Ambulatory Care Centers 76
9.5 Others 77
10 North America Transradial Access System Market, By Geography 78
10.1 North America 78
10.1.1 U.S. 89
10.1.2 Canada 94
10.1.3 Mexico 99
11 North America Transradial Access Market, Company Landscape 104
11.1 Company Share Analysis; North America 104
12 Company Profiles 105
12.1 Cardinal Health 105
12.1.1 Company Overview 105
12.1.2 Revenue Analysis ; Cardinal Health 105
12.1.3 Product Portfolio 106
12.1.4 Recent Developments Recent Developments 107
12.2 Stryker 108
12.2.1 Company Overview 108
12.2.2 Revenue Analysis; Stryker 108
12.2.3 Product Portfolio 109
12.2.4 Recent Developments 109
12.3 Angiodynamics Inc 110
12.3.1 Company Overview 110
12.3.2 Revenue Analysis ; Angiodynamics Inc 110
12.3.3 Product Portfolio 111
12.3.4 Recent Developments 111
12.4 Bd 112
12.4.1 Company Overview 112
12.4.2 Revenue Analysis ; Bd 112
12.4.3 Product Portfolio 113
12.4.4 Recent Developments 113
12.5 Amecath 114
12.5.1 Company Overview 114
12.5.2 Company Snapshot; Amecath 114
12.5.3 Product Portfolio 115
12.5.4 Recent Developments 115
12.6 Boston Scientific Corporation 116
12.6.1 Company Overview 116
12.6.2 Revenue Analysis ; Boston Scientific Corporation 116
12.6.3 Product Portfolio 117
12.6.4 Recent Developments 117
12.7 Edwards Lifesciences Corporation 118
12.7.1 Company Overview 118
12.7.2 Revenue Analysis ; Edwards Lifesciences Corporation 118
12.7.3 Product Portfolio 119
12.7.4 Recent Developments 119
12.8 Medtronic 120
12.8.1 Company Overview 120
12.8.2 Revenue Analysis ; Medtronic 120
12.8.3 Product Portfolio 121
12.8.4 Recent Developments 121
12.9 Merit Medical Systems Inc. 122
12.9.1 Company Overview 122
12.9.2 Revenue Analysis; Merit Medical Systems Inc. 122
12.9.3 Product Portfolio 123
12.9.4 Recent Developments 123
12.10 Nipro Corporation 124
12.10.1 Company Overview 124
12.10.2 Revenue Analysis ; Nipro Corporation 124
12.10.3 Product Portfolio 125
12.10.4 Recent Developments 125
12.11 Oscor Inc 126
12.11.1 Company Overview 126
12.11.2 Company Snapshot; Oscor Inc; 126
12.11.3 Roduct Portfolio 126
12.11.4 Recent Developments 127
12.12 Penumbra 128
12.12.1 Company Overview 128
12.12.2 Revenue Analysis; Penumbra 128
12.12.3 Product Portfolio 129
12.12.4 Recent Developments 129
12.13 Smiths Group Plc 130
12.13.1 Company Overview 130
12.13.2 Revenue Analysis ; Smiths Group Plc 130
12.13.3 Product Portfolio 131
12.13.4 Recent Developments 131
12.14 Teleflex Incorporated 132
12.14.1 Company Overview 132
12.14.2 Revenue Analysis ; Teleflex Incorporated 132
12.14.3 Product Portfolio 133
12.14.4 Recent Developments 133
12.15 Terumo Corporation 134
12.15.1 Company Overview 134
12.15.2 Revenue Analysis ; Terumo Corporation 134
12.15.3 Product Portfolio 135
12.15.4 Recent Developments Recent Developments 136
13 Related Reports 137
?